Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
- PMID: 31836457
- DOI: 10.1016/j.pharmthera.2019.107452
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
Abstract
As a Traditional Chinese Medicine, Paeonia lactiflora Pallas has been used to treat pain, inflammation and immune disorders for more than 1000 years in China. Total glycoside of paeony (TGP) is extracted from the dried root of Paeonia lactiflora Pallas. Paeoniflorin (Pae) is the major active component of TGP. Our research group has done a lot of work in the pharmacological mechanisms of Pae and found that Pae possessed extensive anti-inflammatory and immune regulatory effects. Pae could inhibit inflammation in the animal models of autoimmune diseases, such as experimental arthritis, psoriatic mice and experimental autoimmune encephalomyelitis, and so on. Pae modulates the functions and activation of immune cells, decreases inflammatory medium production, and restores abnormal signal pathway. Pae could balance the subsets of immune cells through inhibiting abnormal activated cell subsets and restoring regulatory cell subsets. Pae could regulate signaling pathways (GPCR pathway, MAPKs /NF-κB patway, PI3K /Akt /mTOR pathway, JAK2 /STAT3 pathway, TGFβ /Smads, and etc.). TGP is composed of Pae, hydroxyl-paeoniflorin, paeonin, albiflorin and benzoylpaeoniflorin etc. Pae accounts for more than 40% of TGP. Like Pae, TGP has anti-inflammatory and immune regulatory effects. TGP has been widely used to treat autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, allergic contact dermatitis, and etc. in China. Furthermore, TGP has some superior features with immune regulation, gentle effect, many indications and few adverse drug reactions. These findings suggest that TGP may be a promising anti-inflammatory and immune drug with soft regulation and has more superiority in the treatment of AIDs. Currently, TGP is used for the treatment of RA, SLE and other AIDs in more than 1000 hospitals in China, which obtained great social and economic benefits.
Keywords: Anti-inflammation and immune regulation; Autoimmune diseases; Paeoniflorin; Total glucosides of paeony; Traditional Chinese Medicine.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have declared no conflicts of interest.
Similar articles
-
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.J Ethnopharmacol. 2020 Aug 10;258:112913. doi: 10.1016/j.jep.2020.112913. Epub 2020 May 1. J Ethnopharmacol. 2020. PMID: 32371143 Review.
-
The effects of total glucosides of paeony (TGP) and paeoniflorin (Pae) on inflammatory-immune responses in rheumatoid arthritis (RA).Funct Plant Biol. 2019 Jan;46(2):107-117. doi: 10.1071/FP18080. Funct Plant Biol. 2019. PMID: 32172753 Review.
-
CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases.Acta Pharmacol Sin. 2020 Nov;41(11):1387-1394. doi: 10.1038/s41401-020-00510-6. Epub 2020 Sep 3. Acta Pharmacol Sin. 2020. PMID: 32884075 Free PMC article. Review.
-
Mechanisms involved in the therapeutic effects of Paeonia lactiflora Pallas in rheumatoid arthritis.Int Immunopharmacol. 2012 Sep;14(1):27-31. doi: 10.1016/j.intimp.2012.06.001. Epub 2012 Jun 21. Int Immunopharmacol. 2012. PMID: 22705050 Review.
-
The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6'-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases.Front Pharmacol. 2019 Feb 5;10:57. doi: 10.3389/fphar.2019.00057. eCollection 2019. Front Pharmacol. 2019. PMID: 30804784 Free PMC article. Review.
Cited by
-
Untargeted Metabolomics Based on UPLC-Q-Exactive-Orbitrap-MS/MS Revealed the Differences and Correlations between Different Parts of the Root of Paeonia lactiflora Pall.Molecules. 2024 Feb 24;29(5):992. doi: 10.3390/molecules29050992. Molecules. 2024. PMID: 38474505 Free PMC article.
-
What can we learn from treatments of oral lichen planus?Front Cell Infect Microbiol. 2024 Feb 15;14:1279220. doi: 10.3389/fcimb.2024.1279220. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38426013 Free PMC article. Review.
-
Paeoniflorin improves ulcerative colitis via regulation of PI3K‑AKT based on network pharmacology analysis.Exp Ther Med. 2024 Feb 5;27(4):125. doi: 10.3892/etm.2024.12414. eCollection 2024 Apr. Exp Ther Med. 2024. PMID: 38414786 Free PMC article.
-
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review.Front Pharmacol. 2024 Feb 9;15:1333657. doi: 10.3389/fphar.2024.1333657. eCollection 2024. Front Pharmacol. 2024. PMID: 38405669 Free PMC article. Review.
-
Exploring the molecular mechanism of Xuebifang in the treatment of diabetic peripheral neuropathy based on bioinformatics and network pharmacology.Front Endocrinol (Lausanne). 2024 Feb 8;15:1275816. doi: 10.3389/fendo.2024.1275816. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38390212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
